HCG Kenya hikes stake in Advanced Molecular Imaging, Kenya

Healthcare Global (Kenya) (HCG Kenya), a step-down subsidiary of Healthcare Global Enterprises (Company), has on 05  October 2026, entered into a Share Purchase Agreement (SPA) with Meditec Systems (Meditec) for acquisition of 10 (Ten) ordinary shares of Advanced Molecular Imaging (AMIL) held by Meditec, for an aggregate consideration of 42,150 Kenyan Shillings (approximately Rs 31,288 as on 05 October 2026). The consideration payable under the SPA has been paid by HCG Kenya on 05 October 2026.

Consequent to the acquisition, HCG Kenya's shareholding in AMIL has increased from 50% to 50.10% of the share capital of AMIL. Accordingly, AMIL, which was an associate of the Company prior to the acquisition, has become a subsidiary of HCG Kenya and, consequently, a step-down subsidiary of the Company.

AMIL is a company incorporated under the laws of Kenya and is engaged in Molecular Imaging / Diagnostic Imaging.